Delayed ventricular repolarization as an anti-arrhythmic principle

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Electrophysiology

Background:

• Cardiac depolarization relies on fast inward currents, with channels inactivating rapidly post-repolarization.
• Class 1 anti-arrhythmic drugs delay inactivation, extending the refractory period.
• Theoretical potential exists to prolong refractory period by delaying cardiac repolarization itself.

Purpose of the Study:

• To investigate the anti-arrhythmic potential of delaying cardiac repolarization.
• To evaluate amiodarone's effect on action potential duration (APD) and its anti-arrhythmic properties.

Main Methods:

• Review of existing literature on anti-arrhythmic drugs and cardiac repolarization mechanisms.
• Analysis of amiodarone's effects on APD and its observed anti-arrhythmic actions in preclinical and clinical studies.

Main Results:

• Quinidine and disopyramide (Class 1 agents) showed minor repolarization delays and had anticholinergic side effects.
• Amiodarone prolonged APD and exhibited anti-arrhythmic effects in various species, including humans.
• Homogeneously prolonged APD is theoretically anti-arrhythmic, despite potential QT prolongation from other causes.

Conclusions:

• Amiodarone's ability to prolong APD offers a viable anti-arrhythmic strategy.
• Agents like amiodarone, bretylium, and sotalol, which prolong APD, are associated with reduced arrhythmia incidence.
• Further research is needed to fully elucidate the mechanisms by which various agents delay cardiac repolarization.